443 related articles for article (PubMed ID: 24370833)
1. Cone dystrophy with "supernormal" rod ERG: psychophysical testing shows comparable rod and cone temporal sensitivity losses with no gain in rod function.
Stockman A; Henning GB; Michaelides M; Moore AT; Webster AR; Cammack J; Ripamonti C
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):832-40. PubMed ID: 24370833
[TBL] [Abstract][Full Text] [Related]
2. Analysis of retinal structure and function in cone dystrophy with supernormal rod response.
Abdelkader E; Yasir ZH; Khan AM; Raddadi O; Khandekar R; Alateeq N; Nowilaty S; AlShahrani N; Schatz P
Doc Ophthalmol; 2020 Aug; 141(1):23-32. PubMed ID: 31960170
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characteristics including in vivo cone photoreceptor mosaic in KCNV2-related "cone dystrophy with supernormal rod electroretinogram".
Vincent A; Wright T; Garcia-Sanchez Y; Kisilak M; Campbell M; Westall C; Héon E
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):898-908. PubMed ID: 23221069
[TBL] [Abstract][Full Text] [Related]
4. Vision in observers with enhanced S-cone syndrome: an excess of s-cones but connected mainly to conventional s-cone pathways.
Ripamonti C; Aboshiha J; Henning GB; Sergouniotis PI; Michaelides M; Moore AT; Webster AR; Stockman A
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):963-76. PubMed ID: 24425859
[TBL] [Abstract][Full Text] [Related]
5. RETINA-specific expression of Kcnv2 is controlled by cone-rod homeobox (Crx) and neural retina leucine zipper (Nrl).
Aslanidis A; Karlstetter M; Walczak Y; Jägle H; Langmann T
Adv Exp Med Biol; 2014; 801():31-41. PubMed ID: 24664678
[TBL] [Abstract][Full Text] [Related]
6. Novel biallelic loss-of-function KCNV2 variants in cone dystrophy with supernormal rod responses.
Kutsuma T; Katagiri S; Hayashi T; Yoshitake K; Iejima D; Gekka T; Kohzaki K; Mizobuchi K; Baba Y; Terauchi R; Matsuura T; Ueno S; Iwata T; Nakano T
Doc Ophthalmol; 2019 Jun; 138(3):229-239. PubMed ID: 30877594
[TBL] [Abstract][Full Text] [Related]
7. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
[TBL] [Abstract][Full Text] [Related]
8. A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response.
Liu PK; Ryu J; Yeh LK; Chen KJ; Tsang SH; Liu L; Wang NK
Ophthalmic Genet; 2021 Aug; 42(4):458-463. PubMed ID: 33960280
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause "cone dystrophy with supernormal rod electroretinogram" in humans.
Wu H; Cowing JA; Michaelides M; Wilkie SE; Jeffery G; Jenkins SA; Mester V; Bird AC; Robson AG; Holder GE; Moore AT; Hunt DM; Webster AR
Am J Hum Genet; 2006 Sep; 79(3):574-9. PubMed ID: 16909397
[TBL] [Abstract][Full Text] [Related]
10. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
[TBL] [Abstract][Full Text] [Related]
11. "Cone dystrophy with supernormal rod electroretinogram": a comprehensive genotype/phenotype study including fundus autofluorescence and extensive electrophysiology.
Robson AG; Webster AR; Michaelides M; Downes SM; Cowing JA; Hunt DM; Moore AT; Holder GE
Retina; 2010 Jan; 30(1):51-62. PubMed ID: 19952985
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.
Lines MA; Hébert M; McTaggart KE; Flynn SJ; Tennant MT; MacDonald IM
Ophthalmology; 2002 Oct; 109(10):1862-70. PubMed ID: 12359607
[TBL] [Abstract][Full Text] [Related]
13. Cone dystrophy with supernormal rod response: novel KCNV2 mutations in an underdiagnosed phenotype.
Zelinger L; Wissinger B; Eli D; Kohl S; Sharon D; Banin E
Ophthalmology; 2013 Nov; 120(11):2338-43. PubMed ID: 23725738
[TBL] [Abstract][Full Text] [Related]
14. Two-color pupillometry in KCNV2 retinopathy.
Collison FT; Park JC; Fishman GA; Stone EM; McAnany JJ
Doc Ophthalmol; 2019 Aug; 139(1):11-20. PubMed ID: 30927187
[TBL] [Abstract][Full Text] [Related]
15. Wide-field fundus autofluorescence abnormalities and visual function in patients with cone and cone-rod dystrophies.
Oishi M; Oishi A; Ogino K; Makiyama Y; Gotoh N; Kurimoto M; Yoshimura N
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3572-7. PubMed ID: 24845635
[TBL] [Abstract][Full Text] [Related]
16. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
Birch DG; Anderson JL; Fish GE
Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in the KCNV2 gene in patients with cone dystrophy and a supernormal rod electroretinogram.
Thiagalingam S; McGee TL; Weleber RG; Sandberg MA; Trzupek KM; Berson EL; Dryja TP
Ophthalmic Genet; 2007 Sep; 28(3):135-42. PubMed ID: 17896311
[TBL] [Abstract][Full Text] [Related]
18. Reliability of Mesopic Measures of Visual Acuity and Contrast Sensitivity and Their Correlation with Rod and Cone Function in Retinitis Pigmentosa.
Bittner AK; Ferraz MC
Ophthalmic Res; 2020; 63(2):133-140. PubMed ID: 31805550
[TBL] [Abstract][Full Text] [Related]
19. Inverse pattern of photoreceptor abnormalities in retinitis pigmentosa and cone-rod dystrophy.
Yokochi M; Li D; Horiguchi M; Kishi S
Doc Ophthalmol; 2012 Dec; 125(3):211-8. PubMed ID: 22865508
[TBL] [Abstract][Full Text] [Related]
20. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.
Khan NW; Wissinger B; Kohl S; Sieving PA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3864-71. PubMed ID: 17652762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
